Advertisement
Screener

Ally Bridge Group (NY) LLC Historic Quarter Change: USA Other Stocks, Sold Out

Ally Bridge Group (NY) LLC historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Ally Bridge Group (NY) LLC opened 9 positions, added to 4, reduced 5 and sold out of 16.

  • Q1 2026: Stock ATAI BECKLEY NV; Country of operation —; Class SHS; Shares before 1,713,105.
  • Q2 2025: Stock SPRINGWORKS THERAPEUTICS INC; Country of operation —; Class COM; Shares before 281,139.
  • Q2 2025: Stock BLUEPRINT MEDICINES CORP; Country of operation United States; Class COM; Shares before 74,192.
  • Q1 2025: Stock INTRA-CELLULAR THERAPIES INC; Country of operation United States; Class COM; Shares before 147,750.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1822947), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-18); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2020-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2026ATAI BECKLEY NV
CUSIP N0731H103
SHS1,713,1050-1,713,105$7,006,599$0-$7,006,5992026-05-18
Q2 2025SPRINGWORKS THERAPEUTICS INC
CUSIP 85205L107
COM281,1390-281,139$12,406,664$0-$12,406,6642025-08-14
Q2 2025BLUEPRINT MEDICINES CORP
CUSIP 09627Y109
United StatesCOM74,1920-74,192$6,566,734$0-$6,566,7342025-08-14
Q1 2025INTRA-CELLULAR THERAPIES INC
CUSIP 46116X101
United StatesCOM147,7500-147,750$12,340,080$0-$12,340,0802025-05-15
Q4 2024LONGBOARD PHARMACEUTICALS IN
CUSIP 54300N103
United StatesCOM240,8920-240,892$8,028,930$0-$8,028,9302025-02-14
Q2 2024LYRA THERAPEUTICS INC
CUSIP 55234L105
United StatesCOM1,003,7410-1,003,741$6,243,269$0-$6,243,2692024-08-14
Q2 2024RAPT THERAPEUTICS INC
CUSIP 75382E109
United StatesCOM420,0000-420,000$3,771,600$0-$3,771,6002024-08-14
Q2 2024MERSANA THERAPEUTICS INC
CUSIP 59045L106
United StatesCOM801,4370-801,437$3,590,438$0-$3,590,4382024-08-14
Q2 2024MARINUS PHARMACEUTICALS INC
CUSIP 56854Q200
United StatesCOM NEW394,7730-394,773$3,568,748$0-$3,568,7482024-08-14
Q1 2024JASPER THERAPEUTICS INC
CUSIP 471871103
COM3,659,2550-3,659,255$28,871,522$0-$28,871,5222024-05-15
Q1 2024CYMABAY THERAPEUTICS INC
CUSIP 23257D103
United StatesCOM489,9380-489,938$11,572,336$0-$11,572,3362024-05-15
Q1 2024INTRA-CELLULAR THERAPIES INC
CUSIP 46116X101
United StatesCOM141,3480-141,348$10,123,344$0-$10,123,3442024-05-15
Q1 2024ALPINE IMMUNE SCIENCES INC
CUSIP 02083G100
United StatesCOM357,2710-357,271$6,809,585$0-$6,809,5852024-05-15
Q1 2024AMBRX BIOPHARMA INC
CUSIP 641871108
COM385,3830-385,383$5,487,854$0-$5,487,8542024-05-15
Q1 2024HARPOON THERAPEUTICS INC
CUSIP 41358P205
United StatesCOM NEW428,4000-428,400$4,870,908$0-$4,870,9082024-05-15
Q1 2024MEDAVAIL HOLDINGS INC
CUSIP 58406B202
COM NEW117,8970-117,897$529,358$0-$529,3582024-05-15

Similar Firms

Firm NameCountry13F ValueHoldings
Marcho Partners LLPUnited Kingdom$0.124B5
WJ Financial Advisors LLCUnited States$0.124B128
Vigil Wealth Management, LLCUnited States$0.124B75
Family Legacy Financial Solutions, LLCUnited States$0.124B48
Post Resch Tallon Group Inc.United States$0.124B120
EDMP, INC.United States$0.124B71
INTREPID FAMILY OFFICE LLCUnited States$0.124B38
Clarity Retirement & Wealth, LLCUnited States$0.124B27
R.H. Dinel Investment Counsel, Inc.United States$0.124B40
NorthLanding Financial Partners, LLCUnited States$0.124B41